BioCentury
ARTICLE | Company News

ImaRx, Abbott deal

April 28, 2008 7:00 AM UTC

ImaRx completed its acquisition of Kinlytic urokinase (formerly Abbokinase) from Abbott after paying the remaining balance of a $15 million promissory note to Abbott. ImaRx acquired urokinase and al...